Cargando…

Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort

BACKGROUND AND AIMS: Air trapping is a predictive index for a decline in lung function and mortality in patients with chronic obstructive pulmonary disease (COPD). However, the role of air trapping in COPD exacerbation has rarely been studied. Therefore, this study aimed to investigate the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Youlim, Kim, Sang Hyuk, Rhee, Chin Kook, Lee, Jae Seung, Lee, Chang Youl, Kim, Deog Kyeom, Shin, Kyeong-Cheol, Jung, Ki Suck, Yoo, Kwang Ha, Park, Yong Bum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965692/ https://www.ncbi.nlm.nih.gov/pubmed/35372402 http://dx.doi.org/10.3389/fmed.2022.835069

Ejemplares similares

Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018
por: Kim, Tae-Ok, et al.
Publicado: (2019)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
por: Lee, Se Hee, et al.
Publicado: (2019)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

Clinical Characteristics of Chronic Obstructive Pulmonary Disease in Female Patients: Findings from a KOCOSS Cohort
por: Choi, Joon Young, et al.
Publicado: (2020)

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Longitudinal change of FEV(1) and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD
por: Jo, Yong Suk, et al.
Publicado: (2019)

Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015–2019
por: Kim, Sang Hyuk, et al.
Publicado: (2023)

Clinical Characteristics and Changes of Clinical Features in Patients with Asthma-COPD Overlap in Korea according to Different Diagnostic Criteria
por: Lim, Jeong Uk, et al.
Publicado: (2020)

Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation
por: Jo, Yong Suk, et al.
Publicado: (2017)

Association Between Air Pollution and Viral Infection in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Juwhan, et al.
Publicado: (2023)

Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
por: Rhee, Chin Kook, et al.
Publicado: (2020)

Increased hospitalizations and economic burden in COPD with bronchiectasis: a nationwide representative study
por: Kim, Youlim, et al.
Publicado: (2022)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD
por: Rhee, Chin Kook, et al.
Publicado: (2015)

Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity
por: Lee, Hyun, et al.
Publicado: (2017)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Jo, Yong Suk, et al.
Publicado: (2021)

Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort
por: Lee, Jung Yeon, et al.
Publicado: (2016)

Natural course of early COPD
por: Rhee, Chin Kook, et al.
Publicado: (2017)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Differences in prevalence of asthma–COPD overlap according to different criteria
por: Song, Jin Hwa, et al.
Publicado: (2018)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study
por: Lee, Ye Jin, et al.
Publicado: (2021)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019)

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
por: Kang, Hye Seon, et al.
Publicado: (2021)

Association of body mass index and COPD exacerbation among patients with chronic bronchitis
por: Shin, Sun Hye, et al.
Publicado: (2022)

Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database
por: Lee, Hyun, et al.
Publicado: (2016)

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database
por: Jo, Yong Suk, et al.
Publicado: (2020)

Heterogeneity of asthma and COPD overlap
por: Kim, Min-Hye, et al.
Publicado: (2018)

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction
por: Jo, Yong Suk, et al.
Publicado: (2018)

What Can We Apply to Manage Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Respiratory Failure?
por: Kim, Deog Kyeom, et al.
Publicado: (2018)

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
por: Lee, Jongmin, et al.
Publicado: (2019)

Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts
por: Song, Jin Hwa, et al.
Publicado: (2018)

Risk of Rapid Lung Function Decline in Young Adults With Chronic Obstructive Pulmonary Disease: A Community-Based Prospective Cohort Study
por: Kim, Sang Hyuk, et al.
Publicado: (2022)

Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
por: Lee, Heock, et al.
Publicado: (2016)

Clinical Features according to the Frequency of Acute Exacerbation in COPD
por: Lee, Seung Jun, et al.
Publicado: (2012)

The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial
por: Ra, Seung Won, et al.
Publicado: (2021)

The Difficulty Of Improving Quality Of Life In COPD Patients With Depression And Associated Factors
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8vdscgice8nren576flmjm9tu5